NYMX

Nymox Pharmaceutical Corp
NYMX

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

50 hedge funds and large institutions have $3.91M invested in Nymox Pharmaceutical Corp in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less first-time investments, than exits

New positions opened: | Existing positions closed:

70% less capital invested

Capital invested by funds: $13.1M → $3.91M (-$9.23M)

Holders
50
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$60K
Puts
$20K
Net Calls
Net Calls Change

Top Buyers

1
+$485K
2
+$294K
3
+$239K
4
HF
HRT Financial
New York
+$189K
5
ECM
ExodusPoint Capital Management
New York
+$117K

Top Sellers

1
-$2.79M
2
-$984K
3
-$826K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$453K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$408K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
–
52
–
53
–
54
–
55
–
56
–
57
–
58
–
59
–
60
–
61
–
62
–
63
–
64
–
65
–
66
–
67
–
68
–
1 2
3